Meeder Asset Management Inc Myriad Genetics Inc Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Meeder Asset Management Inc holds 4,922 shares of MYGN stock, worth $66,447. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,922

Previous 715 588.39%

Holding current value

$66,447

Previous $17,000 688.24%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$23.97 - $28.6 $100,841 - $120,320	4,207 Added 588.39%	4,922 $134,000
Q2 2024 Aug 08, 2024	BUY	$17.98 - $25.47 $12,855 - $18,211	715 New	715 $17,000
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $10,534 - $15,238	726 Added 620.51%	843 $12,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $1,329 - $2,035	73 Added 165.91%	117 $2,000
Q2 2022 Aug 08, 2022	BUY	$16.45 - $25.88 $16 - $25	1 Added 2.33%	44 $1,000
Q1 2022 May 10, 2022	BUY	$22.67 - $28.01 $974 - $1,204	43 New	43 $1,000
Q4 2021 Feb 11, 2022	SELL	$24.13 - $32.63 $88,822 - $120,111	-3,681 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$29.97 - $36.66 $94,225 - $115,259	3,144 Added 585.47%	3,681 $118,000
Q2 2021 Aug 09, 2021	SELL	$25.39 - $32.61 $6,144 - $7,891	-242 Reduced 31.07%	537 $16,000
Q1 2021 Apr 28, 2021	BUY	$19.92 - $31.6 $14,681 - $23,289	737 Added 1754.76%	779 $23,000
Q4 2020 Feb 09, 2021	SELL	$12.16 - $19.77 $42,778 - $69,550	-3,518 Reduced 98.82%	42 $1,000
Q3 2020 Nov 02, 2020	SELL	$11.25 - $14.75 $6,243 - $8,186	-555 Reduced 13.49%	3,560 $46,000
Q2 2020 Aug 11, 2020	BUY	$10.69 - $16.49 $43,989 - $67,856	4,115 New	4,115 $47,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $10,180 - $30,740	-1,041 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $15,948 - $26,746	-762 Reduced 42.26%	1,041 $28,000
Q3 2019 Oct 17, 2019	BUY	$22.08 - $47.08 $39,810 - $84,885	1,803 New	1,803 $52,000
Q2 2019 Aug 05, 2019	SELL	$22.67 - $35.0 $770 - $1,190	-34 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$26.93 - $34.7 $33,312 - $42,923	-1,237 Reduced 97.32%	34 $1,000
Q4 2018 Jan 17, 2019	SELL	$27.23 - $45.56 $137,811 - $230,579	-5,061 Reduced 79.93%	1,271 $37,000
Q3 2018 Nov 02, 2018	SELL	$37.57 - $50.34 $21,076 - $28,240	-561 Reduced 8.14%	6,332 $0
Q2 2018 Jul 24, 2018	BUY	$27.75 - $40.17 $101,953 - $147,584	3,674 Added 114.13%	6,893 $0
Q1 2018 May 03, 2018	SELL	$28.83 - $41.01 $57,400 - $81,650	-1,991 Reduced 38.21%	3,219 $95,000
Q4 2017 Feb 02, 2018	BUY	$28.45 - $37.14 $54,567 - $71,234	1,918 Added 58.26%	5,210 $179,000
Q3 2017 Oct 20, 2017	BUY	$24.01 - $36.2 $79,040 - $119,170	3,292	3,292 $119,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Myriad Genetics Inc Transaction History